(St. Paul, MN)  —  Minnesota medical facilities are suspending the use of two COVID-19 monoclonal antibody therapies.  Medical professionals say they are not effect against the now dominant omicron variant.  Officials say Omicron is widespread and is responsible for over 50-percent of new COVID-19 cases.  Federal estimates say 92-percent of new COVID-19 cases in the Midwest region are caused by the omicron variant.